The New Game for CDMOs: Shifting from Capacity Scale to Knowledge Capabilities The pharmaceutical CDMO industry is currently navigating an unprecedented wave of transformation. Over the past two years, multiple industry reports have consistently indicated that the competitive threshold has
Continue Reading
Taiwanese AI drug discovery startup TherapiAI, in collaboration with the Development Center for Biotechnology (DCB), recently hosted the “Empowering with AI Agents: Data Transformation and Pharmaceutical Innovation” industry forum. The event centered on the practical application and implementation of AI
Continue Reading
TherapiAI Partners with 100+ Global Pharma Firms at Tokyo Expo to Launch International Expansion Enhancing R&D Efficiency and Compliance Management for Pharmaceutical Companies with an AI Agent Decision Platform. Deepening Taiwan-Japan Collaboration to Establish the APAC Market as the Infrastructure
Continue Reading
INTERPHEX Week Osaka is one of Japan’s leading pharmaceutical exhibitions and one of the largest pharma R&D and manufacturing technology shows in Asia. It is held annually at INTEX Osaka, organized by RX Japan Ltd., with support from major pharmaceutical
Continue Reading
TherapiAI Closes Seed Round to Launch Global AI Drug Discovery Expansion Leveraging AI Agents to Enhance Pharmaceutical Efficiency, Reduce Costs, and Shorten R&D Timelines. Based in Taiwan, Expanding to Japan: Creating a Global Platform for Pharma Digital Transformation. AI drug
Continue Reading
As Regenerative Medicine emerges as the next frontier of the global biotech industry, Japan has cemented its status as a pivotal hub in Asia and beyond. This leadership is built upon an advanced regulatory framework and unparalleled manufacturing craftsmanship.From the
Continue Reading
Article Categories
Article Categories
Article Categories
Latest Articles
Follow Us
